Nuvectis Pharma Inc (NVCT)

SG&A Expense Growth

16.67%

Quarterly · Period ending:

NVCT logo

NVCT SG&A Expense Growth

Latest reported16.67%
NVCT Quarterly SG&A Growth (QoQ) (0.00% → 16.67%)
High-resolution chart · PNG

NVCT sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuvectis Pharma Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
16.6667%
-14.8953%
25.297%
-32.2602%
57.9449%
-3.3282%
26.8182%
-9.4118%
-2.0737%
-33.2564%
55.5622%
10.7285%
-12.9181%
-27.1735%
67.9126%
32.7715%
-6.3158%
1.6949%
118.9453%
-69.7578%
7,260.8696%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.